ENT Integrate

The UK ENT Trainee Research Network

[ENT Integrate @ENTIntegrate]

🚨 UK ENT & Audiology colleagues—CIRCA-2 is LIVE!
Help re-audit national cochlear implant referral practice after the PLOS Medicine finding that only ~9% of eligible patients were referred.
🔗 Info:https://t.co/hWwgDfA1s0

Gain PubMed-citable authorship + ST3 points!
#ENT #CIRCA2

[ENT Integrate @ENTIntegrate]

🚨 UK ENT & Audiology colleagues—CIRCA-2 is LIVE!
Help re-audit national cochlear implant referral practice after the PLOS Medicine finding that only ~9% of eligible patients were referred.
🔗 Info:https://t.co/hWwgDfA1s0

Gain PubMed-citable authorship + ST3 points!
#ENT #CIRCA2

[ENT Integrate @ENTIntegrate]

We are delighted to announce our new 2025-2027 committees are now live! Over 90 applications were made for positions, so we are confident that INTEGRATE's mission of trainee led collaborative research is in very safe hands!

https://t.co/CFTa97AO3v

[ENT Integrate @ENTIntegrate]

We are delighted to announce our new 2025-2027 committees are now live! Over 90 applications were made for positions, so we are confident that INTEGRATE's mission of trainee led collaborative research is in very safe hands!

https://t.co/CFTa97AO3v

[IReC @IReC_RM]

🗓️ Tomorrow, 4th October 2025, marks the first-ever Salivary Gland Cancer Day, raising awareness of this rare disease. The 2025 theme highlights the power of unity in creating positive change. Spread the word! #SGCDay #SalivaryGlandCancerDay

[ENT Integrate @ENTIntegrate]

Want to boost your portfolio and earn points towards ST3? TYPHOON is a HRA-approved research study registered on the Associate PI Scheme, and offers an opportunity to get involved in multicentre research!

More information is available our website!

https://t.co/fadBCqo91S

[ENT Integrate @ENTIntegrate]

Want to boost your portfolio and earn points towards ST3? TYPHOON is a HRA-approved research study registered on the Associate PI Scheme, and offers an opportunity to get involved in multicentre research!

More information is available our website!

https://t.co/fadBCqo91S

[ENT Integrate @ENTIntegrate]

Calling all UK ENT Trainees! Get involved in TYPHOON! INTEGRATE are running a national, prospective, multi-centre study investigating the risk factors for post tonsillectomy bleeds.

Sign up your centre now- more information is available on our website!

https://t.co/fadBCqo91S

[ENT Integrate @ENTIntegrate]

Finally, the HN committee have launched TYPHOON, INTEGRATE's first NIHR portfolio study examining the risk factors for post-tonsillectomy haemorrhage.

More information on participation in this national trial is available on the INTEGRATE website!

https://t.co/fadBCqo91S

[ENT Integrate @ENTIntegrate]

Calling all UK ENT Trainees! Get involved in TYPHOON! INTEGRATE are running a national, prospective, multi-centre study investigating the risk factors for post tonsillectomy bleeds.

Sign up your centre now- more information is available on our website!

https://t.co/fadBCqo91S

[ENT Integrate @ENTIntegrate]

Finally, the HN committee have launched TYPHOON, INTEGRATE's first NIHR portfolio study examining the risk factors for post-tonsillectomy haemorrhage.

More information on participation in this national trial is available on the INTEGRATE website!

https://t.co/fadBCqo91S

[ENT Integrate @ENTIntegrate]

INTEGRATE as continued to support @STARFISH_trial, an NIHR sponsored trial comparing intratympanic and systemic steroids for sudden sensorineural hearing loss.

Information on supporting this trial as an associate PI is available on the NIHR website!

https://t.co/BDSpsZ2w4E

[ENT Integrate @ENTIntegrate]

Next is the recently completed national head and neck robotic surgery audit! This project for the first time reported the scope of UK HN robotic surgical practice, in addition to reporting post-operative outcomes.

Keep an eye out for the resulting article in the coming months!

[ENT Integrate @ENTIntegrate]

INTEGRATE as continued to support @STARFISH_trial, an NIHR sponsored trial comparing intratympanic and systemic steroids for sudden sensorineural hearing loss.

Information on supporting this trial as an associate PI is available on the NIHR website!

https://t.co/BDSpsZ2w4E

[ENT Integrate @ENTIntegrate]

Next is the recently completed national head and neck robotic surgery audit! This project for the first time reported the scope of UK HN robotic surgical practice, in addition to reporting post-operative outcomes.

Keep an eye out for the resulting article in the coming months!

[ENT Integrate @ENTIntegrate]

The @STARFISH_trial recently randomised its 200th patient!

With changeover just around the corner, now is the perfect time to sign up to this trial as an Associate PI!

More info is available on the INTEGRARE website!

https://t.co/XbKjCrL4cB

[ENT Integrate @ENTIntegrate]

Next is the National Olfactory Dysfunction audit by our Rhinology committee, reporting variations in the management of this increasingly common condition.

The audit has been presented at BRS & ERS, with an article coming soon in a special edition of Clinical Otolaryngology!

[ENT Integrate @ENTIntegrate]

The @STARFISH_trial recently randomised its 200th patient!

With changeover just around the corner, now is the perfect time to sign up to this trial as an Associate PI!

More info is available on the INTEGRARE website!

https://t.co/XbKjCrL4cB

[The STARFISH Trial @STARFISH_trial]

The @STARFISH trial has now randomised its 200th patient at the Countess of Chester Hospital!

Thank you to all of our collaborating sites on helping us achieve this important milestone!

[ENT Integrate @ENTIntegrate]

Next is the National Olfactory Dysfunction audit by our Rhinology committee, reporting variations in the management of this increasingly common condition.

The audit has been presented at BRS & ERS, with an article coming soon in a special edition of Clinical Otolaryngology!